A Meeting of the FCCB Committee of the Company is scheduled on Wednesday, 19-August-2026 to consider and approve conversion a portion of funds raised through FCCBs into equity shares and ....

PHIRIII IUDARTHAII IIIDUXIRIEI tTD Head Offics : 301, Aura Biplex, Premium Retail Premises, 7, S.V. Road, Borivali {West), fi/umbai - 400092. E.mail : compliance@sudarshanpharma.eom Website: vwvw.sudarshanpharma.com Board Line: +91-22-42221111 i 43331111 142221116 (100line)o611 :1514961r/H2008P1C184997 sPIl-/ cs/sE/ 2026-2027 / 47 Date: 14ft August2026 The Listing Department BSE Limited BSE Scrip Code: 543828 Phiroze Jeejeebhoy Towers, BSE Trading Symbol: SUDARSHAN Daial Street, Mumbai - 400 001 ISIN: INE00TV01023 I)ear Sir/Madam, Sub: Meeting of the FCCB Committee of the Company scheduled to be held on Wednesd ay, 19th August, 2026 Pursuant to Ilegulation29 of SEBI (Listing Obligations and Disclosure Requirements) Reguiations,2075, we wish to inform you that the meeting of the FCCB Committee of tlre Company is scheduled to be held on Wednesday, 19th August,2026, to, inter alia, consider and approve conversion of a portion of fur-rds raisecl through FCCB issue into equity sllares and allotment thereof. Request you to take the same on your record 'l'hanks & Regarc-ls, For, Sudarshan Pharma Industries Limited Shah Company Secretary & iiance Regd. Off. : 301, Aura Biplex, Above Kalyan Jewellers, $,V. Road, Borivali (West), Mumbai - 400092.